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Long-term genomic coevolution of host-parasite
interaction in the natural environment
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Antagonistic coevolution of parasite infectivity and host resistance may alter the biological
functionality of species, yet these dynamics in nature are still poorly understood. Here we
show the molecular details of a long-term phage–bacterium arms race in the environment.
Bacteria (Flavobacterium columnare) are generally resistant to phages from the past and
susceptible to phages isolated in years after bacterial isolation. Bacterial resistance selects for
increased phage infectivity and host range, which is also associated with expansion of phage
genome size. We identiﬁed two CRISPR loci in the bacterial host: a type II-C locus and a type
VI-B locus. While maintaining a core set of conserved spacers, phage-matching spacers
appear in the variable ends of both loci over time. The spacers mostly target the terminal end
of the phage genomes, which also exhibit the most variation across time, resulting in arms-
race-like changes in the protospacers of the coevolving phage population.
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One of the fundamental questions in evolutionary biologyand medicine is how host immunity drives the evolutionof pathogens, as all living organisms are exposed to
infections that can cause signiﬁcant harm and selection in the
host population. The antagonistic coevolutionary arms race of
parasite infectivity and host resistance leads to adaptations and
counter-adaptations in the coevolving partners1–4, and also has a
central role in the evolution of host–parasite relationships in the
microbial world. This arms race has been shown especially under
experimental settings, where lethal infections by bacterial viruses,
(bacterio)phages, shape the diversity and dynamics of the coe-
volving host bacterial populations1, 2, 4, 5, whereas the phages
have the capacity to rapidly overcome host immunity1, 5–9. It has
been suggested, however, that the adaptive potential of phage and
high costs in phage resistance in bacteria can limit
phage–bacterium coevolution10. Yet, the arms-race dynamics
observed in laboratory experiments substantially differ from the
real-life dynamics under the complex web of surrounding inter-
actions present in the environment, which inﬂuences the ecology
and evolution of both phages and their hosts11, 12.
CRISPR (clustered regularly interspaced short palindromic
repeats) and associated cas genes form the bacterial CRISPR-Cas
adaptive immune system against phages and plasmids. CRISPR-
Cas protects bacteria from infections by cleaving invading nucleic
acid sequences (protospacers) that are identical or nearly identical
to the spacers in the bacterial CRISPR repeat-spacer array13, 14.
Protospacer adjacent motifs (PAMs) are used to distinguish self
from non-self and are crucial in most CRISPR systems15, while
protospacer ﬂanking sites (PFSs) determine the efﬁciency of
interference in RNA-targeting CRISPR systems but have no
known autoimmunity-related functions16. Over time, novel
spacers accumulate in one end of the array and may therefore
confer resistance to multiple phages. However, in accordance with
antagonistic coevolution theory, phages can counter-adapt to host
immunity via mutations in the protospacer or PAM/PFS
sequences5, 17, 18, or by using anti-CRISPR proteins19–22.
Following evolutionary change in natural communities is
challenging, and linking genomic change data with the coevolu-
tionary dynamics of phages and bacteria is one of the key chal-
lenges in microbiology. Therefore, a comprehensive view of
host–parasite coevolutionary dynamics in the environment, sur-
rounded by a network of other trophic interactions, is missing. In
fact, previous studies have concentrated either on phenotypic
changes7, 23 or CRISPR genetics using metagenomic approa-
ches24–26. Particularly, empirical evidence on the relative
importance of constitutive and adaptive resistance (mutations
preventing successful phage life cycle and CRISPR loci insertions,
respectively27) in bacteria and the corresponding changes in the
parasitic phage28 supported by phenotypic data from natural
settings is missing. Constitutive and adaptive resistance
mechanisms are predicted to be important in different ecological
conditions29–31, therefore teasing apart the relative role of dif-
ferent bacterial resistance mechanisms is essential for under-
standing microbial community ecology. From an applied
perspective, such information is also crucial for the development
phage therapy applications32, where evolution of resistance is
expected to limit the functionality of the treatment over time.
The importance and volume of aquaculture is growing steadily
to meet the increasing need for high-quality protein for human
consumption33, and new methods such as phage therapy, to
control and manage bacterial diseases are under vigorous
research34, 35. Here, we characterize the coevolution of popula-
tions of bacteriophages and their bacterial hosts (i.e., the ﬁsh
pathogen Flavobacterium columnare36) at the phenotypic and
genetic level, in a ﬂow-through aquaculture setting during the
period 2007–2014. We sampled for bacterial and phage isolates
from the ﬁsh farming facilities or immediate surroundings and
performed all-against-all cross-infections to analyze bacterial
resistance patterns. To link the phenotypic patterns with mole-
cular changes, we sequenced phage genomes to understand the
determinants of the host range and characterized the bacterial
CRISPR loci to understand the role of adaptive immunity in
driving genome evolution and host range in the phage popula-
tion. We report the patterns of arms race coevolution in a natural
community and demonstrate that whereas bacteria evolve resis-
tance, phages evolve a broader host range over time, which is
associated with increase in genome size. We also observed evo-
lutionary change in phage genomes in response to bacterial
adaptive (CRISPR) and constitutive immunity, exemplifying the
importance of both resistance mechanisms in natural bacterial
populations. We also demonstrate a type VI-B CRISPR system
functioning in its natural host and in a natural setting.
Results
Phage and bacterial isolates. F. columnare phages are genotype-
speciﬁc, each infecting strains of only one genotype37. This spe-
ciﬁcity allowed us to analyze both phage and host isolates over
long time scales in locally adapting populations. The phage and
bacteria were collected from a ﬁsh farm in Central Finland mainly
during the warm water season when outbreaks occur. During the
period 2007–2013, we isolated 17 F. columnare isolates that
belong to the genetic group C (Supplementary Table 1). Fur-
thermore, we isolated 30 dsDNA phages (belonging to the family
Myoviridae) during 2009–2014, which infect speciﬁcally this
bacterial host group (Supplementary Table 2).
Coevolution of phage infectivity and bacterial resistance. First,
we analyzed the phage host range by cross-infecting all 30 phage
isolates with all 17 bacterial isolates. The most recently isolated
phages had the widest host range, being able to infect nearly all
bacterial hosts. Analyzed using a time-shift approach38, the phage
isolation time point had a signiﬁcant effect on infectivity com-
pared to the bacterial host. The bacteria were in general resistant
against phages from the past but susceptible to infection by
phages from contemporary and future time points (24% and 18%
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Fig. 1 Time shift of phage–bacterium coevolution in the ﬁsh farming
environment. Phage–bacterium coevolution measured as mean proportion
(± S.E.) of resistant host population, described as annual relative change in
host resistance when exposed to phages from the past (−4 to −1 years),
contemporary (0), and future (+1 to +5 years). The bacteria are in general
resistant against phages from the past but susceptible to infection by
phages from contemporary and future time points (24% and 18% resistant,
respectively; GLMM, F(2, 507)= 15.099, p< 0.001)
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resistant, respectively; generalized linear mixed model (GLMM),
F(2, 507)= 15.099, p< 0.001). The phage isolation year included as
a random factor in this analysis had a signiﬁcant effect (Wald Z=
2.959, p= 0.003), while bacterial isolation place within the farm
(inlet water, outlet water, ﬁsh) or phage enrichment host did not
(Z= 1.36, p= 0.174, Z= 0.586, p= 0.558, respectively). All bac-
teria were resistant to phages from 3–4 years from the past, and,
on the other hand, bacterial resistance was below 0.5% against
phages from 4–5 years in the future (Fig. 1). In addition,
enrichment host did not affect the phage host range (number of
infected hosts, Kruskal–Wallis χ2= 11.7, df= 7, p= 0.103).
We tested phage adsorption efﬁciency of eight phages on nine
bacteria isolated in different years (Supplementary Fig. 1) to see
whether the role of cell surface modiﬁcations over other
resistance mechanisms could be detected. Adsorption efﬁciency
of the phages differed from 0 to 91%. In some cases, adsorption
was less efﬁcient in all or some of the resistant strains indicating
the possibility of resistance via surface modiﬁcations and hence
the lower adsorption efﬁciency for the phage. Also, increased
adsorption was detected in some of the resistant strains (e.g.,
VK42 to B471 and VK58 to B406), which suggest post-adsorption
resistance mechanisms in these pairs. In addition, the efﬁciency of
plating (EOP), adjusted to the titers on strain B230 that was
infected by all phages (Supplementary Table 3), did not relate to
the observed adsorption.
When analyzed using generalized linear mixed models with
adsorption percentage as the response variable, resistance was
found to have no signiﬁcant effect in adsorption. Phages
originating from a previous time point (as compared to the
bacterium) were predicted to have reduced adsorption percentage
(approximately one-third of that of contemporary phages,
GLMM, F(2, 212)= 6.506, Z= −2.722, p= 0.006). No signiﬁcant
difference in adsorption was observed between contemporary and
future phages.
Host resistance drives phage genome evolution. To understand
phenotypic resistance at the genomic level, we sequenced gen-
omes of 17 phage isolates from 2009 to 2014. This resulted in
complete genomes with lengths ranging from 46,481 to 49,084 bp
(Fig. 2; Supplementary Table 2; Supplementary Fig. 2). Phage
genomes from different years were highly similar, enabling us to
study differences at the nucleotide level. From the predicted 74
(2009) to 76 (2014) open reading frames (ORFs), 52 were 100%
identical between all genomes, including putative terminase,
portal protein, and several structural proteins (e.g., major capsid
protein). However, we observed non-synonymous differences in
putative tail and structural proteins (two phages from 2011 in
ORFs 27, 28, and three phages from 2014 in ORFs 36 and 37,
Supplementary Fig. 2). This could indicate a conventional arms
race between phage infectivity and host resistance via receptor
mutation in natural settings (see refs 8, 9 for similar experimental
evolution results).
In multiple sequence alignment, the phage genomes clustered
in three major groups (Fig. 2, marked with symbols). Genomes of
phages in Group 1 (seven phages from 2007 to 2009) were
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Fig. 2 Arms race coevolution of phage infectivity and host resistance at genetic level. The effect of long-term genomic coevolution on phage infectivity and
genome, and on host bacterium CRISPR content. a Spacer diversity in the variable ends of both CRISPR loci (C1 and C2) is indicated by numbered and
colored rectangles above each bacterial strain (each number and color referring to a speciﬁc spacer within a locus). C1 spacers are marked with solid lines
(left spacer column) and C2 spacers with dotted lines (right spacer column). Numbers and colors are locus-speciﬁc and only variable spacers are shown. All
spacers except C1s32, C1s38, and C2s15 are targeting the phages. b Host range of phages (rows) infecting Flavobacterium columnare isolates (columns).
Gray rectangles indicate infection (presence of plaques) and white rectangles indicate resistance. The ﬁrst number within these rectangles indicates the
number of CRISPR spacers with an identical match in the phage genome and the second number the maximum number of phage-targeting spacers the
bacterium has. c Close-up: CRISPR protospacer regions mapped to a ~11 kb portion of the multiple sequence alignment, where the four highlighted
protospacers indicate speciﬁc, possibly CRISPR-driven, changes in these areas. d Patterns of molecular evolution in the phage genomes in response to host
range. Each sequenced phage genome follows the corresponding host range row from b. Green color in the consensus sequence (above) indicates identical
sequence, yellow 30%, and red< 30% identity. Note that also the bar height changes accordingly. Black indicates nucleotide differences and insertion
elements
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identical. In Group 2 phages (four phages from 2010 to 2011),
genomic changes were located at 38,922–43,395 bp (consensus
sequence, in phage VK48 starting from 38,421 bp). According to
Blastp analysis, this genomic region might contain ORFs
associated with phage replication. Furthermore, these differences
were missing in the Group 1 and Group 3 phages (Supplementary
Discussion).
The broadest host range phages (Group 3 with four phages;
isolated in 2014) had changes in putative structural proteins
(ORFS 36 and 37, see above). Interestingly, they, as well as two
phages isolated in 2011 from Group 2 had extra DNA at the
terminal end of their genomes, coding additional predicted ORFs.
All these additional ORFs are located upstream of ORF66, which
has a putative ICE (integrative and conjugative element) domain.
Together with changes in the bacterial CRISPR spacer content
(see below), these genomic differences seem to correlate with a
broader phage host range. The additional ORFs were assigned as
hypothetical proteins. One of these ORFs (no. 67.1) has a
conserved domain belonging to the family of N-acyltransferases
(Supplementary Fig. 2; Supplementary Table 4). Another ORF
(no 74.1) is a putative YopX protein, having also mobile and
extrachromosomal element and prophage functions.
In addition, we found indications that phage infectivity may
signiﬁcantly differ in the three genomic groups (Groups 1, 2, and
3, indicated in Fig. 2). Infectivity was interpreted from EOP
values (Supplementary Table 3; Kruskal–Wallis, χ2= 38.571, df=
2, p< 0.001, Supplementary Fig. 3). However, it should be noted
that here we were not able to test the plaque production against
contemporary bacterial isolates, which may inﬂuence the results.
Characterization of the CRISPR loci and PAM sequences. Next,
using a previously published F. columnare genome sequence39
and our own sequence data, we identiﬁed two CRISPR loci found
in all 17 F. columnare isolates used in this study, designated here
as C1 (CRISPR1, ATCC49512: 391567–394479) and C2
(CRISPR2, ATCC49512: 1680008–1680571) (Supplementary
Fig. 4; Supplementary Table 5). C1 contains Cas9 followed by a
repeat-spacer array and two smaller cas genes (Cas1 and Cas2) in
opposing directions (Supplementary Fig. 4). On the basis of cas
gene composition14 and Cas9 homology40, C1 is a type II-C
CRISPR locus. C2 represents the recently discovered type VI-B
CRISPR system with its large RNA-targeting single-component
endonuclease Cas13b. We conﬁrm that Csx27 and Csx28, small
cas gene regulators associated with some type VI-B systems, are
missing from F. columnare as noted by Smargon et al.41. Two
putative transposases were also discovered immediately down-
stream of this locus.
Repeat-spacer arrays from both loci were sequenced and
corresponding protospacers searched in the phage genomes.
Across all bacterial isolates, a total of 52 unique C1 spacers were
discovered, 18 of which were targeting phage genomes in this
study on both coding and non-coding strands (8 and 10 spacers,
respectively), and both intergenic and predicted ORF regions (5
and 13 spacers, respectively). A total of 29 unique spacers were
discovered in C2. Interestingly, all 15 C2 spacers are targeting
predicted ORFs on the phage coding strand, supporting the
notion that type VI-B systems may be targeting viral
transcripts41.
Protospacer distribution in the phage genomes was biased
toward the terminal end of the genomes (Supplementary Fig. 5)
and differed signiﬁcantly from an expected uniform distribution
in both loci (one-tailed permutation test, C1 p= 0.001, C2 p=
0.016). Roughly half of C1 protospacers were located in the fourth
quadrant of the phage genomes, with C2 protospacers following a
similar yet less pronounced trend.
Analyzing regions surrounding C1 protospacers revealed a
putative downstream PAM sequence of NNNNNTAAAA
(Supplementary Table 6). A similar analysis of C2 protospacer
PFSs supported the ﬁndings of a previous study41 and also
implied possible involvement of C1 acquisition machinery in
C2 spacer acquisition (Supplementary Table 7; Supplementary
Discussion).
Speciﬁcity of the phage–bacterium coevolution. Over time, all
bacterial strains displayed variation in spacer content while
maintaining a large set of conserved spacers shared among all
isolates. The variable ends did not only vary in sequence, but also
in the number of spacers, with the surprising ﬁnding that the
most recent bacteria had generally fewer spacers than older iso-
lates (Fig. 2a). Whereas none of the conserved spacers were tar-
geting phages, the variable ends of the arrays consisted almost
solely of phage-targeting spacers (Fig. 2a; Supplementary Data 1),
exemplifying how exclusively CRISPR evolution is driven by the
phages in close proximity in time and space. Individual bacteria
often contained multiple spacers matching individual phages
(Supplementary Fig. 5), demonstrating the speciﬁcity of the
host–parasite interaction. Furthermore, the incorporation of
novel DNA in the ends of the Group 2 and 3 phage genomes was
followed by the appearance of two CRISPR spacers targeting these
areas (C2s22, C1s52). Surprisingly, however, one spacer
(C2s16) was already present in the bacteria (Fig. 2a) before the
emergence of a novel protospacer-containing sequence in the
phages.
In addition to establishing that new bacterial spacers mostly
originate from phages, we also considered possible coevolutionary
dynamics between the observed spacer and protospacer
sequences. Speciﬁcally, we wanted to see if phage protospacer
or PAM/PFS sequences vary after the appearance of phage-
targeting spacers in the bacterial population. Overall, 6 of the 18
phage-targeting C1 spacers and 9 of the 15 phage-targeting
C2 spacers had altered protospacer sequences in phages isolated
after the appearance of the corresponding spacer in the bacterial
population (Supplementary Fig. 5). Some protospacer alterations
resulted from large re-organizations in the terminal ends of the
genomes, while some were due to very speciﬁc single-nucleotide
polymorphisms or deletions within the protospacer sequences.
Most speciﬁc sequence variations took place on a roughly 11 kbp
area (27,352–38,174 in the consensus sequence). This area is
targeted by four C1 and ﬁve C2 spacers (Fig. 2c; Supplementary
Table 8), and includes six mutational sites (1–12 bp in length).
Four of these mutational sites are located within the C2
protospacers (spacers C2s18, C2s23, C2s28, and C2s29) and their
appearance correlates chronologically with the introduction of the
corresponding spacers to the bacterial population (Supplementary
Fig. 5). Following the appearance of these alternative proto-
spacers, these spacers were no longer detected in later bacterial
isolates. Interestingly, the ancestral protospacer sequence (tar-
geted by spacers C2s18 and C2s23) reappeared in later phage
isolates, which could suggest that bacterial strains harboring these
spacers no longer co-exist.
Currently, knowledge on class 2 afﬁliated anti-CRISPR proteins
is very limited. On the basis on the ﬁndings of a recent study22,
we searched for homologs of the anti-CRISPR proteins AcrIIA1,
AcrIIA2, AcrIIA3, and AcrIIA4 from all the phage genomes in
our data set. No signiﬁcant hits were recovered.
Despite the apparent coevolutionary dynamics displayed by the
CRISPR arrays and phage genomes, linking CRISPR data with
phenotypic infection patterns did not, in most cases, reveal clear
correlation between bacterial resistance and spacer content
(Fig. 2b).
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Discussion
Our results highlight the long-term arms-race coevolution of
hosts and parasites in an aquaculture environment down to the
molecular level. In accordance with previous ﬁndings1, 7–9, the
bacterial population was generally resistant against phages from
past time points and susceptible to infections by (broad host
range) phages from the future. Further molecular characterization
pinpointed genetic changes in both host and phage populations
that ﬁt the assumption of arms-race coevolution. This allows
estimations of the role of constitutive and adaptive immunity as
drivers of parasite infectivity in environmental populations. These
results are especially important for economically relevant condi-
tions that might be suitable for phage therapy approaches.
The evolution of generalist parasites has been shown to arise in
response to host resistance in experimental settings1, 42. Com-
bined with phenotypic resistance patterns, our data suggest that
the evolution of host immunity may have caused directional
selection on phage infectivity and host range via genomic
expansion (Fig. 2; Supplementary Fig. 3). In correlation with
higher infectivity (Supplementary Fig. 1), the genomes of the
most recently isolated phages had larger genome size, increasing
from 46,448 bp (in 2009) to 49,121 bp (in 2014). Phage host range
was independent of the enrichment host used in the original
phage isolation. An earlier isolated enrichment host was always
used (except for ﬁrst ﬁve phages in 2009 (Supplementary
Table 2), however, similar phages could be isolated even when
using different enrichment hosts (e.g., phage pairs VK156 and
VK157, and FCV-10 and FCV-11).
All additional DNA was concentrated in the terminal regions
of the genomes. Although no clear functions for the three addi-
tional ORFs were predicted, structural similarity to a YopX-like
protein was found. Although this protein is an outer membrane
protein of Yersinia, it has been suggested to be linked with the
phage life cycle43. Together with the other additional ORFs (and
deletion of less efﬁcient ones), it could provide an improved
infection cycle. Indeed, when studied over all bacterial isolates,
the host generalist phages isolated most recently were most
infective (Supplementary Fig. 3). This likely results from a com-
bination of phage characteristics, but further genetic studies are
needed for conﬁrmation. From an evolutionary perspective,
parasite host range is expected to correlate negatively with ﬁt-
ness44. Our ﬁnding of parallel increases in host range and
infectivity demonstrates that the evolutionary trajectories of the
phage–bacterium interactions are not yet fully understood.
Genome and gene family expansions have been shown to be
the starting points of evolutionary innovations in eukaryotic
parasites45. These gene family expansions are often located in the
recombinogenic parts of the genome, which could also apply to
the phage genomes in our data set, as the additional ORFs are
found upstream of ORF66, which contains a putative ICE
domain. ICEs integrate in chromosomes and mediate horizontal
gene transfer in bacteria46, but their possible functionality in
viruses has not been characterized. Nevertheless, these phage
genome expansions indicate the role of the surrounding envir-
onment as a source of novel DNA and highlight the importance
of long-term environmental sampling in understanding phage
evolution. Yet, as the physical characteristics of the capsid
strongly constrain phage genome size, our data raise new ques-
tions on what limits the phage host range, virulence, and genome
evolution, and what the associated trade-offs are.
The presence of CRISPR-Cas systems has been found in ~40%
of studied bacterial species40, and the molecular mechanisms of
different CRISPR systems are under active research47. Some
repeat-spacer arrays remain relatively constant over millennia48,
while in some species no two identical CRISPR loci are found
even in cells living in close proximity25. However, previous
CRISPR studies have mainly concentrated on unraveling the
mechanisms of CRISPR immunity in laboratory conditions,
whereas the role of CRISPR immunity for microbial evolutionary
ecology in nature is poorly understood.
Studies on a related bacterium, Flavobacterium psychrophilum,
have discovered inactive CRISPR systems across multiple
strains49, but also high variability between metagenomic samples
from nature50. In F. columnare, we report two active CRISPR loci:
C1, a type II-C system and C2, a recently identiﬁed RNA-
targeting type VI-B system. Two ORFs downstream of C2, whose
translations show possible transposase motifs, may be remnants
from possible horizontal transfer of this locus, see e.g., ref. 40.
Both of the CRISPR loci accumulate novel (mostly phage-tar-
geting) spacers extending the backbone of conserved (not phage-
targeting) spacers (Fig. 2a). On several occasions, the introduction
of CRISPR spacers to the bacterial population was followed by the
appearance of phage isolates with modiﬁcations in the corre-
sponding protospacer regions. This is consistent with studies
demonstrating the appearance of CRISPR-escape mutants due to
altered protospacers5, 17 or PAM regions51. In the four most
speciﬁc protospacer alterations (Fig. 2c), the changes were non-
synonymous, leading to alternative amino-acid sequences in the
predicted ORFs. While promoting evasion of host CRISPR
immunity, these mutations are also likely to have a ﬁtness cost for
the phage. Assuming these non-synonymous mutations arose
before synonymous ones by chance, a possible explanation for
their prevalence may be the large beneﬁt gained from CRISPR-
evasion. In this scenario, the costs of these mutations would only
be unmasked after the disappearance of CRISPR-based selection
pressure, leading to the re-emergence of the ancestral protospacer
sequence. However, our data in this respect are limited and these
predictions require further investigation.
Spacer acquisition is still one of the least known aspects of
CRISPR52. We found an unequal distribution of protospacers in
phage genomes, indicating that CRISPR defense targets the
terminal end of the phage genomes. A recent study showed that
in the type II-A CRISPR system of Streptococcus pyogenes, spacer
acquisition begins while phage dsDNA is being injected inside the
cell53. This results in polarization of spacer acquisition, with most
spacers originating from the phage genome end that ﬁrst enters
the cell. This has been suggested to enrich spacers targeting this
region during selection and less efﬁcient interference by spacers
targeting the opposite end. Typically, in tailed phages (excluding
T4) the end of the packaged genome is the ﬁrst end to be ejec-
ted54. While the packaging and injecting direction of the phage
genomes in our data set is unknown, protospacer distribution
indicates similar polarization as in S. pyogenes. Interestingly, this
genome end also contains most of the variation among the
phages, providing a possible link between the proposed model of
spacer acquisition and the observed patterns of phage genome re-
organization.
The size of the variable ends of the CRISPR loci varied between
the years (Fig. 2a). Surprisingly, the most recent and resistant
bacterial isolates (originating from rainbow trout) contained the
least number of phage-targeting spacers. While the bacterial
isolation source did not signiﬁcantly affect the resistance patterns
(Fig. 2b), it is possible that these bacteria have experienced more
phage encounters during bacterial disease outbreaks, which would
inﬂuence the resistance mechanisms and patterns. It is also
possible that the absolute number of spacers is not a decisive
factor in determining resistance and that spacers vary in effec-
tiveness based on their target sequence (see e.g., ref. 41).
Despite the coevolutionary dynamics observed between spacer
content and phage genomes, CRISPRs could not completely
explain the resistance patterns of the host, possibly due to high
phage pressure in the experimental setup55. However, under low-
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phage selection (such as natural aquatic settings) CRISPRs may
still be preferred over mutation-based immunity due to their
minimal effects on overall ﬁtness of the host30, at least when not
constantly expressed56. Consistent with a previous suggestion57,
the presence of the high diversity of CRISPR spacers (e.g., in
2010) could have reduced phages’ ability to overcome bacterial
resistance by point mutations, and may have caused larger shifts
in the structure of the phage population, observed here as phages
with increased genome size. In addition, adsorption percentages
in infectious and non-infectious phage–bacterium pairs showed
no clear correlation, suggesting that adsorption does not guar-
antee infection. Considering the costs related to maintaining
broad resistance against phages, combining constitutive immu-
nity and diverse CRISPR immunity may be the most successful
strategy for a natural bacterial population58, as the phage have the
potential to rapidly overcome these bacterial defense mechanisms
to ensure their own persistence. The expanding host range driven
by increased genome size is likely to be restricted by the physical
capacity of the capsid. Nevertheless, other factors, such as novel
anti-CRISPR functions, that limit the evolutionary potential of
this speciﬁc phage–bacterium interaction have yet to be dis-
covered. Furthermore, the expansion of the host range may trade-
off with phage infectivity44, which might be the point at which the
adaptive CRISPR defense alone would be sufﬁcient to overcome
those infections.
The bacterial and phage isolates used in this study originate
from a ﬁsh farming environment, a semi-natural system with a
constant ﬂow of incoming environmental water. It is possible that
although attempts to isolate F. columnare phages from waters
outside ﬁsh farming have been mainly unsuccessful37, phages and
bacteria may have already interacted in nature, and the farming
system enriches the phage population sizes to detectable levels.
However, as a man-made environment, the phage–bacterium
interaction is subjected to selection by farming practices, espe-
cially high ﬁsh densities and the use of medication, which may
select for the most virulent and antibiotic tolerant F. columnare
strains59. Thus, by providing essential information on the
phage–bacterium interactions under multifactorial selection in
these settings, our data and study system are directly relevant for
sustainable use of phage therapy applications in ﬁeld conditions.
For example, in laboratory conditions, eliciting phage resistance
in F. columnare has been shown to cause reversible morphotypic
changes that can maintain constitutive resistance60, 61. These
resistant morphotypes are, however, missing from natural iso-
lates, probably because of their impaired growth, tolerance to
protozoan predation and capacity to infect ﬁsh60, 62. The absence
of resistant morphotypes indicates higher beneﬁts of CRISPR
immunity under multifactorial selection in ﬁeld conditions,
although our data show that both constitutive and adaptive
bacterial resistance mechanisms are likely to be active and
important in natural settings.
Methods
Phage and bacterial isolates used in this study. Phage and bacteria were isolated
from a private ﬁsh farm (from ﬁsh and tank water) in Central Finland and from its
immediate surroundings from inlet and outlet water (Supplementary Tables 1 and
2). The isolates were originally collected for other purposes, therefore we do not
have isolates from each year, and from same source, and also different enrichment
hosts were used for phage isolation over the years. The interaction between
F. columnare and its phages is genotype-speciﬁc (each phage type infecting strains
of only one bacterial genotype37), which allowed us to monitor the evolution of
phage–bacterium relationship in this study using a speciﬁc host genotype.
Bacterial strains were originally isolated from water samples and from the ﬁsh
by plating 100 μl of water or gill swabs on Shieh agar63 or Shieh agar supplemented
with tobramycin64, as previously described65. The plates were incubated in room
temperature for 48 h, after which individual yellow rhizoid colonies exhibiting the
typical colony morphology of F. columnare were picked, pure-cultured, and stored
frozen at −80 °C, with 10% fetal calf serum and 10% glycerol. Among the collected
bacterial isolates over the years from this farm, bacteria belonging to genetic group
C were chosen based on ARISA genotyping using the methodology described
previously65, 66. In brief, the intergenic spacer region (between the 16S and 23S
ribosomal genes) of F. columnare isolates was ampliﬁed by PCR. The products were
analyzed using ABI 3130xl Genetic Analyzer to assign the isolates into previously
determined genetic groups.
Phages were isolated from water samples by enrichment. A ﬁltered water
sample (pore size 0.45 μm, Nalgene) was used to dilute ﬁve-fold Shieh medium,
and an overnight-grown enrichment host (belonging to genetic group C) was
inoculated in this medium. Cultures were grown at room temperature (23 °C), at
110 r.p.m. on a benchtop shaker (New Brunswick Scientiﬁc) until they turned
turbid. A double agar layer method was used for detecting phages: 300 µl of turbid
sample with 3 ml of 0.7% soft Shieh agar (tempered to 47 °C) was applied on solid
Shieh agar. After incubation (23 °C) for 24–48 h (depending on the bacterial
growth) plaques were picked. Three rounds of plaque puriﬁcation were performed
for each phage isolate. For further characterization, phage lysates were prepared
adding 5 ml of culture media on a plate with conﬂuent lysis, and shaken at 8 °C, at
95 r.p.m. on a benchtop shaker for 6 h. Phage isolates were stored frozen in −80 °C
with 20% glycerol. Phages were characterized by genome restriction proﬁles using
prior EcoRI experiments, and for this study we used all the phage isolates infecting
the bacterial genetic group C.
Phage host range. For analyzing phage infectivity and host range, a fresh phage
lysate was prepared using host strain C4, which is a non-virulent mutant of
F. columnare67. An overnight-grown bacterial culture (in Shieh medium, 23 °C,
110 r.p.m.) of the test strains was plated using the double agar overlay method by
mixing bacterial culture 1:10 with 0.7% soft Shieh agar tempered to 47 °C and
pouring this on agar plates. The phage was diluted until million fold (10−6), and 10
µl samples of each dilution was spotted on top of the bacterial lawn. All bacterial
strains were infected with all phages in a pairwise manner. After incubation of 48 h,
the plates were checked for single plaques. Plaque formation was considered as a
positive result for phage infectivity.
Time-shift experiment and statistical analysis. Bacterial resistance in response
to phages from past, contemporary, and future time points was analyzed with
generalized linear mixed models using SPSS 22.0. This was done using the infection
data presented in Fig. 2, and we calculated the proportion of resistance of bacteria
in relation to the temporal difference of isolation of each phage. In the statistical
analysis, the response variable of phage infection was encoded as a binary trait,
therefore binomial distribution with logit link transformation was used. Time shift
was used as a ﬁxed factor and phage isolation year, bacterial isolation place and
phage enrichment host as random factors, with bacterial identity as a blocking
factor (subject). Only phages able to produce plaques in the host bacteria were
considered infective in the analysis.
Adsorption assay. Adsorption efﬁciency of eight phages to nine bacterial hosts
(Supplementary Fig. 1) during 20 min was measured following the method by
Kropinski 200968 with modiﬁcations. In brief, bacteria were grown to exponential
phase and diluted to ~3×108 colony forming units ml−1. A total volume of 3 ml was
used in the assay: 0.3 ml of phage suspension (adjusted to 1–3×105 plaque forming
units (PFU) ml−1) was added to 2.7 ml of bacterial culture. Phage added to Shieh
medium without bacteria was used as a control. The assays were done in three
replicates. After 20 min a sample of 50 μl was diluted to 950 μl of cold growth
media supplemented with three drops of chloroform. PFU ml−1 of the free phage
particles was determined by plating 100 μl of the sample with C4 strain using the
double agar overlay method. Adsorption data were analyzed using a generalized
linear mixed model with adsorption percentage as the response variable (binomial
distribution and logit link) using R 3.3.3 and RStudio 1.0.136. Time shift (past,
contemporary, and future phage) and bacterial resistance were used as explanatory
variables and replicate identities as random factors. In the few cases where the
observed number of plaques in VK20 exceeded the control values due to mea-
surement error due to instrumental or observational error (i.e., having 110 plaques
resulting from a bacterial adsorption tube, when only 100 plaques were extracted
from the control tube), the adsorption percentage was ﬁxed to 0.
Phage genome sequencing. Phages subjected to genome sequencing were chosen
based on their infection proﬁles (Fig. 2). Phage DNA was isolated using a protocol
described by Santos69 with slight modiﬁcations. Brieﬂy, after RNase (10 μg ml−1)
and DNase (1 μg ml−1) treatment phages were precipitated with 40 mM ZnCl2 and
incubated for 5 min followed by pelleting (15,000 × g, 5 min) and resuspended in
TES buffer (0.1 M Tris-HCl, pH 8; 0.1 M EDTA; 0.3% SDS). DNA was puriﬁed
using a GeneJET Genomic DNA isolation kit column (Fermentas). About 100 ng of
DNA was subjected to genome sequencing with Illumina MiSeq in Institute for
Molecular Medicine Finland (FIMM), apart from isolate FCV-1, which was
sequenced using Roche 454 at LGC Genomics, Germany.
Genome assembly. The phage genomes were assembled using Velvet-assembler
(v. 1.2.10)70 with optimal k-mers per genome (average coverage ~×1600). Differ-
ences appearing in only one genome were checked and corrected if needed. Single
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insertions and nucleotide differences were checked by sequencing directly from the
genome using speciﬁc primers (Supplementary Table 7). ORF’s were predicted
using GeneMarkS (v. 4.28)71 and Glimmer (v. 3.02b)72. Protein Homology/analogY
Recognition Engine V 2.0 (PHYRE2)73 was used for predicting protein structures.
CRISPR sequencing and analyses. Bacterial DNA was extracted from overnight-
grown turbid cultures using the GeneJET Genomic DNA isolation kit (Fermentas).
We used the previously published F. columnare ATCC 49512 genome39 and our
own unpublished sequence data as references in designing primers for amplifying
the CRISPR loci. NetPrimer (Premier Biosoft) was used for the analysis. Primers
(Supplementary Table 9) were provided by Sigma. CRISPR loci from the extracted
DNA were ampliﬁed in a PCR reaction (PIKO Thermal cycler by Finnzymes) using
the Phusion Flash II polymerase in a 20 µl reaction with a template concentration
of 0.5 ng µl−1. The protocol was completed following the manufacturer’s instruc-
tions. The annealing temperature was 65 °C for CRISPR1 and 67 °C for CRISPR2,
and the elongation step was 30 s for CRISPR1 and 27 s for CRISPR2. The reactions
were puriﬁed for sequencing using the QIAquick PCR Puriﬁcation Kit (Qiagen).
The ampliﬁed PCR products were sequenced with the Sanger method. Raw data
were transformed using SequenceAnalysis 6 basecalling. Two replicates were done
for each read and the consensus sequences were manually determined using
Geneious 9.1.4 (Biomatters Ltd.).
The determination of the orientations of the CRISPR loci (namely, the
transcription direction of the repeat-spacer arrays) was based on analyses using
CRISPRDetect74, comparisons with other similar CRISPR systems and observations
of the polarization of spacer acquisition. Unlike in most CRISPR systems, the crRNA
in type II-C systems is transcribed starting from the conserved end75. By assuming
this transcription direction, we could detect a conserved PAM sequence downstream
of C1 protospacers. As all type II systems described so far exhibit downstream PAMs,
we assume that the C1 repeat-spacer array is also transcribed starting from the
conserved end. Very low conﬁdence values associated with C1 direction prediction by
CRISPRDetect led us to not use this tool with this locus. However, CRISPRDetect was
able to produce conﬁdent direction prediction values for the C2 repeat-spacer arrays,
which are in line with those of a previous study31 and which place the transcription
initiation point at the variable end, as in most CRISPR systems. This direction also
enables the spacers to target messenger RNA (mRNA) from predicted viral ORFs and
produces PFSs in line with those of a previous study31.
All spacers across all isolates were pooled and labeled according to their
CRISPR locus, creating global spacer pools for both loci. Spacers were numbered
starting from the conserved end of the oldest strain, B425 (in which the oldest
C1 spacer is called C1s1 and the most recent one C1s37). After labeling all B425
C1 spacers, we proceeded to the next strain (B447) and searched for any novel
spacers, labeling them by adding to the global C1 numerical sequence (e.g., C1s38).
Eventually, each C1 and C2 spacer in the total spacer pool had a locus-speciﬁc ID.
Each spacer may be isolate-speciﬁc (e.g., C2s29) or shared by two or more isolates
(e.g., C1s48). In C1, a 114 bp area containing degenerate repeats between spacers 4
and 5 was skipped, and numbering was resumed downstream of this area.
The C1 PAMs are reported using the guide-centric approach76. Due to the
RNA-targeting nature of C2, the PFSs reported here are obtained from the single-
stranded mRNA of the predicted ORFs using the target-centric approach.
Protospacer location analysis. Possible bias in the distribution of protospacers on
the phage genomes was analyzed by comparing the actual protospacer location
means against simulated sets of protospacers distributed randomly and uniformly
over a 50,666 bp long genome (the size of the consensus sequence). The mean
protospacer positions (18 spacers for C1, 15 spacers for C2) of each of these
permutations (100,000 simulations) was used as the statistic for creating a null
distribution. The observed means from the collection of 18 C1 (mean position
35706.61) and 15 C2 (mean position 33342.33) protospacers were compared to this
distribution and p-values calculated as the proportion of the simulated means
exceeding the observed ones over the total number of simulations. These analyses
were conducted with R 3.3.3 and RStudio 1.0.136.
It must be noted that the possible effects of primed spacer adaptation have not
been taken into account in these analyses. Priming has not been shown to affect
spacer acquisition beyond class I systems52 and by current knowledge requires the
cascade complex and the Cas3 nuclease77, which are missing from the CRISPR loci
of F. columnare.
Analysis. Geneious (v. 9.1.4) was used for the annotation and analysis of the
CRISPR sequence data, and phage PAM and PFS extractions. WebLogo (v. 3.5.0)
was used to create sequence logos of the PAM and PFS sequences.
Data availability. Phage genome sequences are available in GenBank (accession
numbers KY951963, KY951964, KY979235-KY979247, KY992519, KY992520). All
other data are included in the supplementary ﬁles and available from the authors.
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